NBY Competitors & Alternatives
Compare NovaBay Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
NBY
Main Stock$1.95
Tradestie Score
50
Market Cap
$8.23M
Revenue Growth
-0.8%
Analyst Upside
-56.4%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.83
|
$133.50M | - | 66 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.03
|
$114.01M | - | 55 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$25.01
|
$110.20M | - | 61 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.47
|
$71.69M | - | 58 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$9.83
|
$67.94M | - | 59 | Compare |
|
SINT
SiNtx Technologies, Inc. Common Stock
|
$1.90
|
$11.23M | - | 51 | Compare |
|
SNGX
Soligenix, Inc. Common Stock
|
$0.40
|
$10.38M | - | 50 | Compare |
|
OGEN
Oragenics Inc.
|
$0.58
|
$5.86M | - | 49 | Compare |
|
CFOR
CFOR
|
- | - | - | - | Compare |
|
GHSI
GHSI
|
- | - | - | - | Compare |
More NBY Analysis
Data updated: Jun 25, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry